AVERAGED AND TIME-GATED SPECTRAL-ANALYSIS OF RESPIRATORY SOUNDS - REPEATABILITY OF SPECTRAL PARAMETERS IN HEALTHY-MEN AND IN PATIENTS WITH FIBROSING ALVEOLITIS
Ara. Sovijarvi et al., AVERAGED AND TIME-GATED SPECTRAL-ANALYSIS OF RESPIRATORY SOUNDS - REPEATABILITY OF SPECTRAL PARAMETERS IN HEALTHY-MEN AND IN PATIENTS WITH FIBROSING ALVEOLITIS, Chest, 109(5), 1996, pp. 1283-1290
Study objective: To obtain a basis for assessment of changes in breath
sound spectra in patients with pulmonary diseases, short-term and day
-to-day repeatability of spectral parameters was studied. Design: Brea
th sounds were recorded simultaneously from the trachea and from the c
hest twice at an interval of 15 min (short-term repeatability) and of
1 to 3 days (day-to-day repeatability), During recordings, air flow at
the mouth was controlled, the target inspiratory and expiratory peak
flow being 1.25 L/s. Inspiratory and expiratory breath sound spectra w
ere averaged over 7 to 10 successive respiratory cycles, The repeatabi
lity of sound intensity (RMS), frequency of maximum intensity (Fmax),
and median frequency (F50) was analyzed with analysis of variance. Par
ticipants: Short-term repeatability was studied in 10 healthy nonsmoki
ng men (age 25 to 44 years), and day-to-clay repeatability was studied
in 10 healthy nonsmoking men (age 23 to 41 years) and in 12 patients
with clinically stable fibrosing alveolitis (age 35 to 82 years). Resu
lts: Short-term coefficient of variation (CoV) of Fmax and F50 was 2.6
to 6.7% when recorded from the chest, and 6.2 to 8.7% when recorded f
rom the trachea. Day-to-day CoV of Fmax and F50 in healthy subjects wa
s 4.7 to 8.5% and 5.0 to 8.7% recorded from the chest or from the trac
hea, respectively. Inspiratory day-to-day variation in those parameter
s was higher in patients with fibrosing alveolitis, CoV of RMS was hig
h, ranging from 18 to 47% in different subject groups and sampling sit
uations. Conclusions: Repeatability of F50 of averaged flow-controlled
lung sound spectra is good both in healthy subjects and in patients w
ith fibrosing alveolitis. Thus, F50 of respiratory sound spectra may b
e useful in monitoring of changes induced by respiratory diseases and
interventions. These results emphasize the importance of standardizati
on of recording conditions and of analyzing techniques.